NASDAQ : ASRT
Assertio Holdings, Inc. — Key statistics
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 23.5 USD (At close: Jun 15, 2026) · Market cap 151.86M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 151.86M |
| Enterprise Value | 120.61M |
Dates
| Measure | Value |
|---|
| Earnings Date | May 8, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 6.46M |
| Shares Outstanding | 6.46M |
| Shares Change (YoY) | +0.86% |
| Shares Change (QoQ) | +0.22% |
| Owned by Insiders (%) | 3.05% |
| Owned by Institutions (%) | 28.60% |
| Float | 6.26M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 19.26 |
| PS Ratio | 1.49 |
| Forward PS | 1.22 |
| PB Ratio | 2.00 |
| P/TBV Ratio | 4.67 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.18 |
| EV / EBITDA | 31.51 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.82 |
| Quick Ratio | 1.45 |
| Debt / Equity | 0.53 |
| Debt / EBITDA | 9.91 |
| Debt / FCF | n/a |
| Interest Coverage | -7.37 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -38.76% |
| Return on Assets (ROA) | -5.71% |
| Return on Invested Capital (ROIC) | -39.50% |
| Return on Capital Employed (ROCE) | -19.00% |
| Weighted Average Cost of Capital (WACC) | 6.94% |
| Revenue Per Employee | $1.93M |
| Profits Per Employee | -$673,396 |
| Employee Count | 53 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 0.97 |
Taxes
| Measure | Value |
|---|
| Income Tax | 235,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.53 |
| 52-Week Price Change | +147.94% |
| 50-Day Moving Average | 21.16 |
| 200-Day Moving Average | 14.45 |
| Relative Strength Index (RSI) | 83.59 |
| Average Volume (20 Days) | 305,875 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 334,922 |
| Short Previous Month | 249,299 |
| Short % of Shares Out | 5.18% |
| Short % of Float | 5.35% |
| Short Ratio (days to cover) | 0.71 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 102.16M |
| Gross Profit | 71.85M |
| Operating Income | -22.75M |
| Pretax Income | -35.46M |
| Net Income | -35.69M |
| EBITDA | 3.83M |
| EBIT | -22.75M |
| Loss Per Share | -$5.56 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 71.57M |
| Total Debt | 40.31M |
| Net Cash | 31.26M |
| Net Cash Per Share | $4.84 |
| Equity (Book Value) | 75.63M |
| Book Value Per Share | 11.73 |
| Working Capital | 75.28M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -7.08M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 26.58M |
| Net Borrowing | n/a |
| Free Cash Flow | -7.08M |
| FCF Per Share | -$1.10 |
Margins
| Measure | Value |
|---|
| Gross Margin | 70.33% |
| Operating Margin | -22.27% |
| Pretax Margin | -34.71% |
| Profit Margin | -34.94% |
| EBITDA Margin | 3.75% |
| EBIT Margin | -22.27% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.86% |
| Shareholder Yield | -0.86% |
| Earnings Yield | -23.50% |
| FCF Yield | -4.66% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $24.43 |
| Price Target Difference | 3.96% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | -4.66% |
| EPS Growth Forecast (3Y) | 40.88% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Dec 26, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -3.91 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |